Steering Committee

Jennifer Aversano, BSN, RN, OCN, BMTCN
Oncology Nurse Navigator
Advocate Lutheran General Hospital
Park Ridge, IL

Jennifer Aversano, BSN, RN, OCN, BMTCN, is a double-certified oncology nurse navigator with a specialty in lung cancer at Advocate Lutheran General Hospital in Park Ridge, Illinois. In this role, she identifies all newly diagnosed lung cancer patients and helps them with any barriers and with navigation through the continuum of care. Ms. Aversano is also the point of contact for the lung cancer screening program, providing education to patients and follow-up recommendations to ordering physicians guided by the multidisciplinary lung tumor board.

She is the current system chair of the Advocate Navigation/Survivorship forum in the Advocate Health Care system, the largest integrated healthcare system in Illinois, which recently merged with Wisconsin’s largest healthcare system, Aurora Health Care.  Ms. Aversano presented a poster with her colleagues at the 2018 American Society of Clinical Oncology (ASCO) annual meeting on a “Community Based Lung Cancer Screening Program: An Evaluation of the Initial Lung Cancer Screening CT Scan.”

She received her bachelor’s degree from Elmhurst College in Elmhurst, Illinois, and is currently pursuing a master’s degree in Nursing at Lewis University in Romeoville, Illinois.

Stephen Cattaneo, MD
Medical Director of Thoracic Oncology, Division Director of Surgical Oncology
Anne Arundel Medical Center
Annapolis, MD
David Feller-Kopman, MD, FCCP, Professor of Medicine
Director of Bronchoscopy and Interventional Pulmonology
Johns Hopkins Hospital
Baltimore, MD

Dr. Feller-Kopman serves as the Director of Bronchoscopy and Interventional Pulmonology at Johns Hopkins.  He is an expert in the minimally invasive diagnosis and staging of lung cancer. His areas of clinical expertise include all aspects of interventional pulmonology, including minimal invasive diagnostic procedures to evaluate suspicious lung nodules and enlarged lymph nodes in the chest as well as the evaluation and management of malignant and non-malignant central airway obstruction.  In addition, he specializes in the evaluation and management of pleural diseases with minimally invasive procedures such as ultrasound guided thoracentesis, indwelling pleural catheters and thoracoscopy with pleurodesis.  He is a fellow of the American College of Chest Physicians and the American Thoracic Society, as member of the Miller-Coulson academy of Clinical Excellence at Johns Hopkins.

Dr. Feller-Kopman’s research focuses on the minimally invasive treatment of patients with malignant pleural effusion. Dr. Feller-Kopman co-founded the Interventional Pulmonary Outcomes Group (IPOG) whose mission is to provide and support multicenter prospective trials in the Interventional Pulmonary space.  He is also involved with several projects investigating minimally invasive ways to diagnose and treat lung cancer.  His goal is to advance the science of Interventional Pulmonology in order to improve the quality of life of patients with malignant pleural effusions and central airway obstruction as well as to develop new strategies to diagnosis and treat lung cancer.

He completed his internship and residency at Beth Israel Hospital, Harvard University; a Fellowship in Pulmonary and Critical Care, Combined Harvard Program (Massachusetts General Hospital, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center; and a Fellowship: Interventional Pulmonary, Beth Israel Deaconess Medical Center, Harvard University. He is board certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine, and Interventional Pulmonary.

Jhanelle Gray, MD
Program Co-Leader, Molecular Medicine Chair, Department of Thoracic Oncology
Moffitt Cancer Center
Tampa , FL
Xiuning Le, MD
Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX
Percy Lee, MD
Professor and Vice-Chair of Clinical Research
Medical Director, Orange County and Coastal Radiation Oncology
City of Hope National Medical Center
Los Angeles, CA

Dr. Percy Lee is professor and vice-chair of Clinical Research and medical director for Orange County and Coastal Regions in the Department of Radiation Oncology at City of Hope National Medical Center. Dr. Lee has an international reputation in the treatment of thoracic and gastrointestinal malignancies. His research interests include applying novel technologies, such as MRI-guided radiation therapy, in the clinic and he led the clinical implementation of MRI-guided radiation therapy program at the University of California Los Angeles (UCLA), only the third site in the world with this innovation. In addition, he is a clinical trialist who is interested in combining novel radiation therapy approaches with new drugs to achieve improved outcomes in thoracic malignancies.

Dr. Lee began his career at UCLA, where he rose to the rank of professor and vice chair of Education for the Department of Radiation. There, he also served as chief of Thoracic Radiation Oncology, Residency Training Program director, and director of the Stereotactic Body Radiation Therapy Program. Subsequently, Dr. Lee served as section chief of Thoracic Radiation Oncology at MD Anderson Cancer Center from 2019-2022. In addition to these posts, Dr. Lee has served on various leadership roles within national organizations such as the American Society for Radiation Oncology, the American Board of Radiology, American Radium Society, and the Radiosurgery Society.

Dr. Lee earned his bachelor’s degree in biomedical engineering from Johns Hopkins University in Baltimore, Md. and his medical degree from Harvard Medical School in Boston, Mass. He completed his clinical internship in internal medicine at Massachusetts General Hospital, his residency in radiation oncology at Stanford University in California, and is board certified in Radiology. Dr. Lee was born and raised in Taipei, Taiwan until the age of 9, and still has family throughout the island.

Michelle Shiller, DO, AP/CP, MGP
Co-Medical Director of Genetics, Baylor Sammons Cancer Center
Staff Pathologist, Baylor University Medical Center
Dallas, TX

Michelle Shiller, DO, AP/CP, MGP, became board certified in Anatomic, Clinical, and Molecular Genetic Pathology following the completion of her residency at Baylor University Medical Center in Dallas, Texas, and her fellowship at The Mayo Clinic in Rochester, Minnesota. Upon completion of her training, Dr. Shiller established a practice with Pathologists Biomedical Laboratories in Dallas, Texas, which services the majority of the Dallas/Ft. Worth Metroplex Baylor Scott and White Hospitals. Dr. Shiller sits on the Quality Committee for the Baylor Sammons Cancer Center; serves as the Assistant Medical Director for Cancer Genetics, primarily focusing on germline cancer predisposition; and is the Co-Assistant Medical Director for the Division of Molecular Medicine and Pathology. Dr. Shiller has also served on the Baylor Medical Board. Dr. Shiller has served on steering committees and advisory boards for multiple entities. She is an active member of the Association for Molecular Pathology, where she has developed a consistent dialogue between molecular pathology and oncology, and she assists with developing the ASCO-sponsored Molecular Tumor Board..

Brendon Stiles, MD
Associate Professor, Cardiothoracic Surgery
New York-Presbyterian Hospital, Weill Cornell Medicine
New York, NY

Dr. Stiles is an Associate Professor of Cardiothoracic Surgery at New York-Presbyterian Hospital, Weill Cornell Medicine. 

Dr. Stiles is a busy clinician, with expertise in the surgical management of lung cancer and other thoracic malignancies. Dr. Stiles is also an active basic science researcher focused on lung cancer. He is the Chair of the Board of Directors of the Lung Cancer Research Foundation (LCRF); Dr. Stiles is a grant reviewer for LCRF, the Thoracic Surgery Foundation, and the CDMRP Lung Cancer Research Program.

He is a member of numerous professional organizations, including the National Lung Cancer Roundtable, and an active advocate for lung cancer research and for patients.

Jamie L. Studts, PhD
Professor of Behavioral Science
University of Kentucky College of Medicine
Lexington, Kentucky

Jamie L. Studts, PhD, is a professor of behavioral science at the University of Kentucky College of Medicine and assistant director for cancer prevention and control within the Markey Cancer Center. Dr. Studts is a licensed clinical health psychologist, and his interests address behavioral aspects of tobacco-related malignancies. His research develops and tests interventions to promote informed/shared decision-making and behavior change among patients and clinicians regarding prevention, screening, and survivorship of lung and head/neck cancer.

Dr. Studts is the principal investigator of the Kentucky LEADS Collaborative, and he served on the Institute of Medicine National Cancer Policy Forum addressing Implementation of Lung Cancer Screening. He is a fellow of the Society of Behavioral Medicine and a member of the Scientific Leadership Board for the GO2 Foundation for Lung Cancer and the American Cancer Society National Lung Cancer Roundtable, serving as chair of the Survivorship, Stigma, and Nihilism Task Group.

Marc Vimolratana, MD
Assistant Professor, Department of Cardiothoracic & Vascular Surgery
Montefiore Medical Center
Bronx, NY
Benjamin Wei, MD
Associate Professor Program Director, Cardiothoracic Surgery Residency
Heersink School of Medicine University of Alabama at Birmingham
Birmingham, AL
Jack West revised head shot
Howard (Jack) West, MD
Executive Director, AccessHope; Associate Clinical Professor​, City of Hope Comprehensive Cancer Center
Duarte, CA

H. Jack West, MD, is Associate Clinical Professor and Executive Director of Employer Services at City of Hope Comprehensive Cancer Center in Duarte, California.

Prior to this, he was a medical oncologist and Medical Director of the Thoracic Oncology Program at Seattle Cancer Institute, in Seattle, Washington. He founded and serves as President of the Global Resource for Advancing Cancer Education (GRACE), a nonprofit that provides free information for patients and caregivers dealing with cancer.

Dr. West serves as Web Editor of JAMA Oncology. He leads a wide range of continuing medical education programs and other educational programs, including hosting the podcast, West Wind. Dr. West trained at Princeton University, University of Cambridge, Harvard Medical School, Brigham & Women’s Hospital, and Fred Hutchinson Cancer Research Center.